These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
655 related articles for article (PubMed ID: 15617731)
1. Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576. Chauhan NB; Siegel GJ; Feinstein DL Neuropharmacology; 2005 Jan; 48(1):93-104. PubMed ID: 15617731 [TBL] [Abstract][Full Text] [Related]
2. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985 [TBL] [Abstract][Full Text] [Related]
3. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867 [TBL] [Abstract][Full Text] [Related]
4. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice. Tan X; Liang Z; Li Y; Zhi Y; Yi L; Bai S; Forest KH; Nichols RA; Dong Y; Li QX Behav Brain Res; 2021 Feb; 398():112968. PubMed ID: 33069740 [TBL] [Abstract][Full Text] [Related]
5. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563 [TBL] [Abstract][Full Text] [Related]
6. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro. Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556 [TBL] [Abstract][Full Text] [Related]
7. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice. Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765 [TBL] [Abstract][Full Text] [Related]
8. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease. Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552 [TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A. Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003 [TBL] [Abstract][Full Text] [Related]
10. Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model. Long ZM; Zhao L; Jiang R; Wang KJ; Luo SF; Zheng M; Li XF; He GQ CNS Neurosci Ther; 2015 Nov; 21(11):887-97. PubMed ID: 26385876 [TBL] [Abstract][Full Text] [Related]
11. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease. Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984 [TBL] [Abstract][Full Text] [Related]
12. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J; Levy M; Dickson DW; Potter H Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [TBL] [Abstract][Full Text] [Related]
13. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease. Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371 [TBL] [Abstract][Full Text] [Related]
14. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset. Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293 [TBL] [Abstract][Full Text] [Related]
15. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice. Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613 [TBL] [Abstract][Full Text] [Related]
16. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737 [TBL] [Abstract][Full Text] [Related]
17. Curcumin Decreases Hyperphosphorylation of Tau by Down-Regulating Caveolin-1/GSK-3β in N2a/APP695swe Cells and APP/PS1 Double Transgenic Alzheimer's Disease Mice. Sun J; Zhang X; Wang C; Teng Z; Li Y Am J Chin Med; 2017; 45(8):1667-1682. PubMed ID: 29132216 [TBL] [Abstract][Full Text] [Related]
18. Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice. Jin G; Wang LH; Ji XF; Chi TY; Qi Y; Jiao Q; Xu Q; Zhou XY; Zhang R; Zou LB Neurosci Lett; 2014 Jun; 573():58-63. PubMed ID: 24810883 [TBL] [Abstract][Full Text] [Related]
19. The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease. Lanzillotta A; Sarnico I; Benarese M; Branca C; Baiguera C; Hutter-Paier B; Windisch M; Spano P; Imbimbo BP; Pizzi M J Mol Neurosci; 2011 Sep; 45(1):22-31. PubMed ID: 21181298 [TBL] [Abstract][Full Text] [Related]
20. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]